PVP-Guided Decongestive Therapy in HF

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 586 participants.

Also called NCT05217342

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 586 participants (planned count) (from the registry)
Sponsor
Marmara University (from the registry)
Registry
  • NCT NCT05217342
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Türkiye (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05217342. Randomized; no masking; primary purpose treatment. Start 2022-01-01 (actual); primary completion 2024-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PVP-Guided Decongestive Therapy in HF
Acronym
PERIPHERAL-HF
Condition
Heart Failure
Condition
Edema
Condition
Volume Overload
Condition
Heart Failure,Congestive
Intervention (Drug)
Diuretic therapy
Lead sponsor
Marmara University (class: other)
Collaborator
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital (class: other)
Collaborator
Başakşehir Çam & Sakura City Hospital (class: other government)

Record details

Record id
cardio:ct-nct05217342
Content hash
287e5b746aff368ae30dba853bbbe71731a88c6b3072031797bcfa90c3d02c9c